Blog

PA Emerging Technologies Caucus visits Ben Franklin in the Navy Yard

September 2, 2021

Representatives Napoleon Nelson and Melissa Shusterman of the Emerging Technologies Caucus visited our Navy Yard offices in August to learn about blockchain, robotics and other innovative technologies that are helping build transformative companies and communities across the Commonwealth. Watch their recaps of their visit here. We need small innovative companies to stay here in PA. […]

Read More

Centers for Medicare & Medicaid Services Issues New Code for Encala®

September 1, 2021

Envara Health, a company committed to making significant advancements in the field of clinical nutrition, today announced that the Centers for Medicare and Medicaid Services (CMS) has issued a new Healthcare Common Procedure Coding System (HCPCS) code for Encala®, a structured lipid matrix powder for oral administration. This decision establishes the S9432 code, “Medical Food […]

Read More

Nexteon Technologies Completes First Commercial Aviation Cyberattack Detection Flight Test

August 30, 2021

Nexteon Technologies, Inc., a leader in advanced aviation technologies, announced today that it has completed the first in-flight test simulating a cyberattack on an Automatic Dependent Surveillance-Broadcast (ADS-B)-equipped aircraft. During the 30-minute flight, Nexteon’s SecureTrack™ technology was able to successfully detect and characterize the intrusion and generate security alerts. The test was conducted on July […]

Read More

Excision Announces NIH Martin Delaney Grant Awarded to Temple University to Support “CRISPR for Cure” for HIV

August 30, 2021

Excision BioTherapeutics Inc, the developer of CRISPR-based therapies intended to cure viral infectious diseases, today announced that the Temple University team collaborating with Excision on a project, CRISPR for Cure, has received a Martin Delaney Grant from the National Institutes of Health (NIH) of $4.8 million on an annual basis for the next five years […]

Read More

Biomeme & Predigen Merge to Enable Point-of-Care Delivery of Host Response Tests That Address Critical Unmet Needs in Healthcare

August 27, 2021

Biomeme, the leading provider of portable PCR testing solutions, has signed a definitive agreement to acquire Predigen, a privately held diagnostic company and emerging leader in precision medicine focused on host response diagnostics. Predigen’s acquisition will expand Biomeme’s capabilities across infectious disease and clinical microbiology, business management, and commercialization. redigen’s portfolio includes flagship host gene […]

Read More

Previous Next